2013
December
- "Is it necessary to understand the MoA?"
- Christopher A Bravery, PhD
- Speaker, chair intro
- Informa’s 4th Annual Cell Therapy Manufacturing
- Brussels, Belgium.
October
- "Potency Assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry"
- Dr. Christopher Bravery, PhD
- Speaker, moderator
- IBC’s 3rd Annual Cell Therapy Bioprocessing Conference
- Bethesda, USA.
June
- "Understanding Mechanisms of Action and Identifying Relevant Biological Activities: Why are they so important?"
- Dr. Christopher Bravery, PhD
- Speaker
- PDA Europe, Advanced Therapy Medicinal Products Conference
- Florence, Italy.
- "Navigating the Uncertainties of Product Quality"
- Dr. Christopher Bravery, PhD
- Speaker
- IChemE, Biomedical Engineering Special Interest Group: Product Development in Regenerative Medicine.
- London UK.
April
- "19th Annual ISCT Meeting"
- Dr. Christopher Bravery, PhD
- Preconference GRP chair, session chair.
- Skycity Auckland Convention Center
- Auckland, New Zealand
January
- Workshop moderator and "Potency ISCT-PPD"
- Dr. Christopher Bravery, PhD
- Workshop, speaker
- "Phacilitate. Cell & Gene therapy forum 2013".
- Grand Hyatt, Washington, DC.